Sec. 1379.052.  COVERAGE REQUIRED.  A health benefit plan issuer shall provide benefits for routine patient care costs to an enrollee in connection with a phase I, phase II, phase III, or phase IV clinical trial if the clinical trial is conducted in relation to the prevention, detection, or treatment of a life-threatening disease or condition and is approved by:
(1)  the Centers for Disease Control and Prevention of the United States Department of Health and Human Services;
(2)  the National Institutes of Health;
(3)  the United States Food and Drug Administration;
(4)  the United States Department of Defense;
(5)  the United States Department of Veterans Affairs; or
(6)  an institutional review board of an institution in this state that has an agreement with the Office for Human Research Protections of the United States Department of Health and Human Services.
Added by Acts 2009, 81st Leg., R.S., Ch. 719 (S.B. 39), Sec. 1, eff. September 1, 2009.